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Abstract
Cinnamon is one of the most important herbal drugs and has been widely used in Asia for more than 4000 years. As a 
folk medicine, cinnamon  has been traditionally applied to the treatment of inflammatory disorders and gastric diseases. 
After chemical profiling of cinnamon’s components, their biological activities including antimicrobial, antiviral, 
antioxidant, antitumor, antihypertension, antilipemic, antidiabetes, gastroprotective and immunomodulatory were 
reported by many investigators. As a result, current studies have been performed mostly focusing on the bioactivity of 
cinnamon toward the recently generalized metabolic syndrome involving diabetes. In this review article, we provide an 
overview of the recent literature describing cinnamon’s potential for preventing the metabolic syndrome.
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Introduction
The genus Cinnamon is an aromatic tree belonging 
to the family Lauraceae, and is one of the most widely 
studied flowering families, comprising about 250 
species. Members of this family are evergreen trees, 
up to 10-17 m high, that grow in south-eastern Asia, 
Australia, and South America (Cheng, 1983). The 
flowers are bisexual, colored yellow with 9 stamens, 
and the fruits occur mostly as 10-15- mm long black 
ellipsoids (Cheng, 1983). Traditional uses of Cinnamon 
throughout Asia, Africa, and Europe have been 
recorded, where it has been used as a medicine for 
diarrhea, nausea and chill, or as a spice for seasoning 
meats. Cinnamon bark (肉桂 ròu guì) is an important 
source for these purposes, since it contains a great 
amount of the function-bearing essential oil. The bark-
derived cinnamon (termed cinnamon hereafter) contains 
45% ~ 65% cinnamaldehyde, 12% ~ 18% eugenol 
(Cheng, 1983) and  small amounts of cinnzeylanine, 
cinnzeylanol, arabinoxylan, 2’-hydroxycinnamalde-
hyde, and 2’-benzoloxycinnamaldehyde (Lee, 1999). 
As a major ingredient, cinnamaldehyde has been 
well investigated; and its diverse biological activities 
against  central nervous system depression (Harada, 
1976) and high blood pressure (Harada, 1975), as 
well as its analgesic effect (Harada, 1972), have been 
reported. A water extract of cinnamon was reported to 
have anti-allergic, anti-inflammatory (Nagai, 1982a; 
1982b; 1982c), antipyretic, analgesic (Ozaki,1972) 
and antithrombotic effects (Terasawa, 1983). Recently, 
This is an open access article under the CC BY-NC-ND license.
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the interest of investigators seems  to have shifted 
to become narrowly centered on the verification of 
cinnamon’s potential for preventing the metabolic 
syndrome (Kannappan, 2006; Blevins, 2007) and 
diabetes (Anderson, 2004; Chase, 2007; Pham, 2007; 
Shen, 2010).
This  review summarizes  the up-to-date  and 
comprehensive information on cinnamon regarding 
its traditional use, for which modern scientists have 
solved its pharmacological functions together with its 
toxicological aspects. Then we discuss a possible trend 
and scope for future research on cinnamon.
Cinnamon as a traditional medicine
Trees belonging to the genus Cinnamomum are one 
of the major materials used in  traditional Chinese 
medicine. Preparations containing the bark of Cinnamon 
have been prescribed for more than 2000 years in China, 
where the first record of its use was described in the 
Divine Husbandman’s Herbal Foundation Canon (see 
the review introduced by Cheng, 1983). Owing to its 
roles in dispelling colds (祛寒 qū hán), threading an 
occluded vasa vasorum, and controlling yin/yang (陰
陽 yīn yang) as mentioned in the old Chinese literature, 
cinnamon has been widely used in China and Japan for 
the treatment of fever and inflammation as well as for 
improvement of an appetite depressed by influenza or 
the common cold (Cheng, 1983). In addition, cinnamon 
has been used as an aromatic for the preparation of fruit 
juices, wine, and cakes as well as for cooking meat. 
Cinnamon extracts have been used for the improvement 
of or protection against the common cold, diarrhea, and 
pain (Cheng, 1983). It has also been reported that the 
cinnamon ameliorates nephritis, purulent dermatitis, and 
hypertension, as well as potentiates wound healing, even 
that due to snake or viper bites (Nagai, 1982a; 1982b; 
Cheng, 1983). However, these effects are not fully 
supported by experimental or clinical data so far.
Functional components in Cinnamomum 
plants
Cinnamaldehyde is a major constituent (45~65% 
of the essential oil in cinnamon bark) of the plants 
belonging to genus Cinnamomum  (Cheng, 1983). 
Eugenol is contained as a second major constituent; and 
cinnzeylanine, cinnzeylanol (Isogai, 1977), arabinoxylan 
(Gowda, 1987), 2’-hydroxycinnamaldehyde, and 
2’-benzoloxycinnamaldehyde (Lee, 1999) are also 
detected. Chemical structures of these compounds 
are shown in Fig. 1. A hot-water extract of cinnamon 
sticks (dried barks of cinnamon trees) yields 8.5 mg/ml 
cinnamaldehyde and 3.6 mg/ml cinnamyl alcohol (Shen, 
2010).
Pharmacological effects of cinnamon
In vitro  and in vivo  studies on cinnamon extracts 
or its components (mainly cinnamaldehyde) revealed 
that these substances exhibit a wide variety of 
pharmacological effects, such as antifungal, anti-
cardiovascular, anticancer, antiinflammatory, antiulcer, 
antidiabetes, antiviral, antihypertensive, antioxidant, 
and cholesterol- and lipid-lowering ones. Some of 
the relevant literature on these therapeutic effects is 
summarized in Table 1, and some of the observations 
made are discussed in the following sections.
Antifungal effect
The antifungal activity of cinnamaldehyde, which is 
used as a vapor to treat respiratory tract mycoses, has 
been reported. Cinnamon tree power (we usually call 
it “cinnamon”) acts against infectious fungi including 
Aspergillus niger, A. fumigatus, A. nidulans, A. flavus , 
Candida albicans , C. tropicalis , C. pseudotropicalis , 
Figure 1. Compounds found in the Cinnamon barks
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and Histoplasma capsulatum (Singh, 1995; Lima, 1993; 
Quale, 1996). In these cited studies, the following data 
were reported: the minimum inhibitory concentration 
(MIC), minimum lethal concentration (MLC) and 
exposure duration for its fungicidal action at MIC 
and higher doses, as well as incubation temperatures 
for expression of its fungitoxicity. The inhalation of 
cinnamaldehyde  appears to be an ideal chemotherapy 
against respiratory tract mycoses.
Effects on cardiovascular system and gastrointestinal 
tract 
Cinnamophilin in cinnamon was found to be a 
thromboxane A2 (TXA2) receptor-blocking agent; and 
therefore its antagonistic effect was shown in TXA2-
induced human platelet aggregation, rat aortic ring 
contraction, and contraction of guinea pig tracheal rings 
(Yu, 1994a). Intravenous administration of arachidonic 
acid (50 μg/kg body weight) to a guinea pig induces 
bronchoconstriction, whereas when  cinnamophilin is 
pre-administered (0.1 mg/kg body weight, i.v.  at 1 min 
before arachidonic acid), the bronchoconstriction is 
abolished (Yu, 1994a). Cinnamophilin (1-15 μM) also 
possesses a voltage-dependent Ca2+ channel-blocking 
action, which was judged from its antagonism toward 
high K+(60 mM)- and Bay K 8644 (0.1 μM)-induced 
contraction of rat thoracic aorta (Yu, 1994b). Su et 
al . demonstrated that the inhibition of sodium inward 
current, calcium inward current, and transient outward 
currents of both may contribute to the anti-arrhythmic 
activity of cinnamophilin against  ischemia-reperfusion 
arrhythmia (Su, 1999). 
Anticancer and immunomodulatory activities
An early study on water-soluble extracts of cinnamon 
showed that it increases the glutathione S-transferase 
(GST) activity in mice administered urethane, a 
carcinogenic substance, and prevents carcinogenesis 
(Abraham, 1998). Furthermore, an aqueous extract 
of cinnamon reduces cellular proliferation and blocks 
the cell cycle of Jurkat, Wurzburg, and U937 cells at 
the G2/M phase (Schoene, 2005). Cinnamaldehyde 
or its source C. cassia  powder is reportedly a potent 
inducer of apoptosis in human promyelocytic leukemia 
cells, in which the aldehyde stimulates an apoptotic 
cascade leading to the activation of caspase-3 (Ka, 
2003, Nishida, 2003). 2’-Hydroxycinnamaldehyde and 
2’-benzoloxycinnamaldehyde isolated from the bark 
Table 1. Pharmacological activity of cinnamon and its compounds
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of C. cassia  show  cytotoxicity against several human 
solid tumor cells such as HCT-15 and SK-MEL-2 cells 
(Lee, 1999). Koh et al . (1998) reported that both of 
these compounds inhibit lymphocyte proliferation and 
modulate T-cell differentiation in vitro.  
Antiulcerative activity
The antiulcerative effect of a cinnamon extract has 
not yet been clarified, but the effect of a water extract of 
cinnamon on serotonin-induced gastric lesions in mice 
was studied. A palliative effect is observed after oral 
administration of the extract at a dosage of 5–10 mg/kg  
body weight (Keller, 1992).
Antiinflammatory activity
Nagai et al. (1982a, 1982b) proved that complement-
dependent reactions including reversed passive 
cutaneous anaphylaxis, Forssman cutaneous vasculitis, 
nephrotoxic serum nephritis classified as type II, and 
the Arthus reaction classified as type III are  clearly 
inhibited by an aqueous extract of C. cassia. However, 
this extract does not affect the nephritis caused by the 
F(ab')2 portion of the nephrotoxic IgG antibody. The 
aqueous extract of C. cassia  at a high concentration 
(200 mg/kg body weight) inhibits the immunological 
hemolysis and the chemotactic migration of neutrophils 
caused by activated serum complement as well as the 
generation of chemotactic factors. They also showed 
that the type IV reaction found in contact dermatitis 
is not affected by the aqueous extract of C. cassia but 
that the production of hemolytic plaque-forming cells 
is slightly inhibited by it. Their findings suggest that an 
aqueous extract of C. cassia  has an anti-complement 
activity and inhibits complement-dependent allergic 
reactions. 
Antioxidant activity
Mancini-Filho et al . (1998) demonstrated the 
antioxidant activity of cinnamon extracts by using an 
oxidative β-carotene/linoleic acid system, and they 
suggested that the cinnamon extracts can be used not 
only for improvement of food palatability but also for 
prevention of food oxidation. 
Cinnamon bark extracts prepared with water and 
alcohol as well as its essential oil were tested in two 
different in vitro  systems, i.e., peroxynitrite-induced 
nitration and lipid peroxidation. The essential oil and its 
component eugenol both show antioxidant activity in 
these systems (Shobana, 2000; Dragland, 2003; Khan, 
2003; Chericoni, 2005; Kim, 2006a).
Cinnamon barks from C. zeylanicum , C. cassia 
or other cinnamon species are reported to exhibit 
antioxidant and free radical-scavenging activities, some 
of which were measured by using 1,1-diphenyl-2-
picrylhydrazine (DPPH; Mancini-Filho, 1998; Shobana, 
2000; Okawa, 2001; Dragland, 2003).
Cholesterol- and lipid-lowering effects
Administration of cinnamon to mice increases their 
HDL-cholesterol level and decreases their plasma 
triglyceride one (Kim, 2006a). Khan et al . (2003) 
reported that cinnamon improves the blood glucose, 
triglyceride, total cholesterol, HDL cholesterol and LDL 
cholesterol levels in patients with type 2 diabetes.  
Antidiabetes effect 
Recently, the anti-diabetic effect of cinnamon 
has been studied intensively by many investigators 
(Anderson, 2004; Chase, 2007; Pham, 2007; Shen, 
2010). They commonly found that cinnamon improves 
insulin resistance and glucose metabolism in vitro and 
in vivo (Subash, 2007; Kannappan, 2006; Kim, 2006a; 
Berrio, 1992; Broadhurst, 2000; Cao, 2007; Imparl-
Radosevich, 1998; Jarvill-Taylor, 2001; Khan, 1990; 
Kim, 2006b; Kreydiyyeh, 2000; Lee, 2011; Roffey, 
2006; Taher, 2004; Talpur, 2005; Onderoglu, 1999; 
Qin; 2003; Qin, 2004; Verspohl, 2005). Among the 
components of cinnamon, cinnamaldehyde significantly 
and dose-dependently decreases the plasma glucose 
concentration of streptozotocin-induced diabetic 
rats (Subash, 2007). Regarding the mechanism 
underlying these effects, Shen et al . (2010) reported 
that cinnamon extracts promote the transportation of 
glucose by glucose transporter 4 in brown adipose 
tissue and muscles. Clinical research studies support 
the positive effects of cinnamon on both types 1 and 2 
diabetes mellitus (Mang, 2006; Suppapitiporn, 2006; 
Vanschoonbeek, 2006; Altschuler, 2007; Blevins, 2007; 
Wang, 2007). 
Conclusions
As has been reported, cinnamon, as forms of bark, 
bark powder, extracts or its isolated components, has 
multifunctional activities promoting the health of human 
beings. Different from therapeutic drugs, cinnamon can 
be used daily in our diet without ill effect. Therefore, it 
may be preventive especially against the lifestyle-related 
illness or metabolic syndrome.
Although we did not mention in this review on 
cinnamon that it is also a representative agonist of the 
transient receptor potential A1 (TRPA1) cation channel 
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(Iwasaki, 2008), many of the pharmacological activities 
of cinnamon might be exhibited via this receptor; 
e.g. the effects on cardiovascular and gastrointestinal 
systems might be regulated more or less by nervous 
systems via  TRPA1. The ant icancer  and ant i -
inflammatory activities could also be explained partly 
by sympathetic nerves stimulated via TRPA1. 
Taking the self-protective antifungal and antioxidant 
activities of cinnamon into account, cinnamaldehyde, 
cinnamophilin, and other components possess both 
direct and indirect activities; i.e., the antifungal and 
antioxidant activities occur by direct action on fungus 
or oxidant, whereas the antidiabetic, anticancer, and 
antiinflammatory ones occur indirectly via some yet 
undefined receptor-mediated mechanisms.
The remarkable health benefits of cinnamon prompt 
us to explore derivatives of cinnamon that might 
be much more useful structures for overcoming the 
metabolic syndrome. 
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